Guest Writer
LP defaults on capital calls remain rare, but the pressure on investors is real. Here’s a practical look at the contractual realities, the options available to GPs and LPs, and why the playbook is evolving, from Alexander Branton, the CIO of Nodem Capital.
The fund vehicle offers real flexibility for managers at the moment, write Ajay Pathak and Chris Ormond of the law firm Goodwin.
CFOs must shift mindset and upgrade operations to be equipped to meet the demands of a fast-evolving private markets landscape, says CSC’s Marshall Saffer.
With secondaries becoming a more popular pathway to exit, it’s key to acknowledge the complexity of valuations, according to Valuation Research Corporation’s Subu Parmeswaran.
As private fund CFOs face growing pressure for liquidity, forecasting, payment connectivity and facility management are emerging as the pillars of an advanced treasury model, say CSC’s Chantal Drost and Ram Chandrasekar.
All managers should be thinking about their treasury set-up and anticipate future needs to manage risks while maximizing use of scarce resources, says Alpha Alternatives’ partner, treasury practice, Danny Olds.
Volatile rates have pushed liquidity management to the forefront, technology is getting more central with better automation and forecasting , while flexibility remains key, says Victory Park Capital’s Andrew Murray.
The year’s M&A market answered the pressures and volatility of the playing field with creativity and AI-tools, and look to the do the same in 2026, according to Colin Schopbach, Americas chief revenue officer at Datasite.
Public and private markets have evolved in such a way that 'sophistication' is an outdated standard to divide the two, argues Chris Hayes, a partner at the government affairs firm Thorn Run Partners.
In a rebounding biotech market, royalty finance can play a far more strategic role, provided it’s executed with disciplined underwriting, smart structuring and a genuine partnership with innovators, according to Ryan Murr a partner at Gibson, Dunn & Crutcher.